A Plus Biotechnology Co., Ltd. (TPE:6918)
Taiwan · Delayed Price · Currency is TWD 68.90
-1.20 (-1.71%)
Jul 30, 2026, 12:38 PM CST
A Plus Biotechnology Financials Overview
Financials in millions TWD. Fiscal year is January - December.
Millions TWD. Fiscal year is Jan - Dec.
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
Revenue Revenue Growth | 858.89 | 835.89 | 769.59 | 675.05 | 541.85 | 503.29 |
Revenue Growth | 8.99% | 8.62% | 14.01% | 24.58% | 7.66% | - |
Gross Profit Gross Profit Growth | 577.93 | 573.46 | 534.78 | 460.67 | 346.39 | 317.93 |
Operating Income Operating Income Growth | 208.31 | 208.76 | 182.46 | 167.54 | 46.74 | 42.53 |
Net Income Net Income Growth | 173.26 | 169.38 | 151.06 | -11.31 | 32.94 | 36.06 |
Earnings Per Share EPS Growth | 5.12 | 5.15 | 4.97 | -0.37 | 1.14 | 1.26 |
EPS Growth | -1.71% | 3.62% | - | - | -9.52% | - |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 |
|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 |
Adjustment and Write-Off Adjustment and Write-Off Growth | -72.25 | -66.58 | -60.45 | -72.38 |
China China Growth | 181.96 | 175.3 | 161.55 | 151.52 |
Taiwan Taiwan Growth | 749.18 | 727.17 | 668.5 | 595.9 |
Total Total Growth | 858.89 | 835.89 | 769.59 | 675.05 |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
Cash & Investments Cash & Investments Growth | 611.23 | 608.35 | 390.97 | 319.07 | 306.09 | 290.31 |
Total Debt Total Debt Growth | 171.51 | 96.1 | 106.81 | 113.03 | 204.87 | 38.68 |
Net Cash (Debt) Net Cash Growth | 439.72 | 512.26 | 284.16 | 206.03 | 101.22 | 251.64 |
Net Cash Growth | 31.03% | 80.27% | 37.92% | 103.55% | -59.77% | - |
Net Cash Per Share Net Cash Per Share Growth | 13.00 | 15.57 | 9.36 | 6.81 | 3.50 | 8.79 |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
Operating Cash Flow Operating Cash Flow Growth | 158.25 | 158.91 | 160.96 | 159.1 | 52.95 | 112.21 |
Capital Expenditures CapEx Growth | -135.07 | -14.12 | -8.87 | -9.38 | -221.5 | -4.86 |
Free Cash Flow Free Cash Flow Growth | 23.18 | 144.79 | 152.09 | 149.72 | -168.55 | 107.35 |
Free Cash Flow Growth | -86.88% | -4.80% | 1.58% | - | - | - |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
Gross Margin | 67.29% | 68.60% | 69.49% | 68.24% | 63.93% | 63.17% |
Operating Margin | 24.25% | 24.98% | 23.71% | 24.82% | 8.63% | 8.45% |
Pretax Margin | 25.76% | 25.86% | 24.37% | 0.45% | 8.50% | 9.49% |
Profit Margin | 20.17% | 20.26% | 19.63% | -1.68% | 6.08% | 7.17% |
FCF Margin | 2.70% | 17.32% | 19.76% | 22.18% | -31.11% | 21.33% |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 |
|---|---|---|---|---|
| Period Ending | Jul '26 Jul 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 |
Dividend Per Share Dividend Per Share Growth | 5.000 | 5.000 | 4.000 | 2.700 |
Dividend Per Share Growth | 25.00% | 25.00% | 48.15% | - |
Dividend Yield | 6.97% | 6.21% | 5.49% | 6.77% |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
| Period Ending | Jul '26 Jul 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
PE Ratio | 13.69 | 17.45 | 16.18 | - | - | - |
P/FCF Ratio | 103.05 | 20.41 | 16.07 | 9.22 | - | - |
PS Ratio | 2.78 | 3.54 | 3.18 | 2.05 | - | - |